Uncontested runway: the obstacles management narrates are execution and time, not rivals
The model's full reasoning — Q1 2024 call → NOThe question asks whether management's account of growth obstacles centers on its own execution and the calendar, rather than competition for demand. Let me analyze the transcript. Key elements: 1. Management describes growth in Oracle and SAP segments, with Oracle up 26% and SAP up 26% due to value-added reseller activity. 2. The global S&BT segment is down 3% due to extended decision-making and economic headwinds, particularly in e-procurement. 3. GenAI initiatives - AI Explorer platform launched, with 175+ demo meetings, and engagements expected to increase. 4. Management discusses investments in sales resources, training, and development. Now, the critical question: Does management frame the obstacles to more business as its own execution and calendar, or as competition for demand? Looking at the transcript: - The S&BT segment weakness is attributed to "extended client decision-making" and "economic headwinds" - this is external conditions, not competition. - The GenAI opportunity is described as significant, with AI Explorer receiving favorable feedback, but revenue impact was nominal in Q1. - Management says they expect engagements to increase throughout Q2. The obstacles narrated: - Extended decision-making (external condition) - Economic headwinds (external) - GenAI investment considerations (external market shift) - Lower conversion rates in executive advisory (though they attribute this to needing to integrate GenAI content) Is there a "real path to more business, already being worked"? Management describes AI Explorer demos, engagements, and investments. But the revenue impact is nominal, and they're still building capabilities. Is the contest for demand absent? Management doesn't really discuss competitors, win rates, or pricing battles. The obstacles are external conditions (extended decision-making, economic headwinds) and their own readiness (integrating GenAI content, building capabilities). However, the question asks specifically: are the obstacles management narrates ITS OWN EXECUTION AND THE CALENDAR, rather than other sellers competing for the same demand? The obstacles are: 1. Extended decision-making due to economic conditions - this is external, not execution 2. GenAI market shift requiring them to integrate content - this is somewhat their own execution (they started integrating in April) 3.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| NOAH | Noah Holdings Limited | Q1 2024 | 2024-05-30 | D |
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| RCEL | AVITA Medical, Inc. | Q1 2024 | 2024-05-14 | F |
| ERO | Ero Copper Corp. | Q1 2024 | 2024-05-10 | A |
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| ECPG | Encore Capital Group, Inc. | Q1 2024 | 2024-05-08 | B |
| FWONK | Formula One Group | Q1 2024 | 2024-05-08 | C+ |
| LINC | Lincoln Educational Services Corporation | Q1 2024 | 2024-05-06 | B+ |
| NC | NACCO Industries, Inc. | Q1 2024 | 2024-05-05 | C+ |
| PPC | Pilgrim's Pride Corporation | Q1 2024 | 2024-05-03 | A |
| CW | Curtiss-Wright Corporation | Q1 2024 | 2024-05-02 | B+ |
| TTI | TETRA Technologies, Inc. | Q1 2024 | 2024-05-01 | A |
| WEC | WEC Energy Group, Inc. | Q1 2024 | 2024-05-01 | A |
| ROCK | Gibraltar Industries, Inc. | Q1 2024 | 2024-05-01 | B+ |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| ASB | Associated Banc-Corp | Q1 2024 | 2024-04-25 | A |
| PDS | Precision Drilling Corporation | Q1 2024 | 2024-04-25 | B |
| GL | Globe Life Inc. | Q1 2024 | 2024-04-23 | F |
| CLGN | CollPlant Biotechnologies Ltd. | Q4 2023 | 2024-04-04 | F |
| DUOT | Duos Technologies Group, Inc. | Q4 2023 | 2024-04-01 | F |
| ASM | Avino Silver & Gold Mines Ltd. | Q4 2023 | 2024-03-21 | C+ |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| PBR | Petróleo Brasileiro S.A. - Petrobras | Q4 2023 | 2024-03-08 | D |
| MNKD | MannKind Corporation | Q4 2023 | 2024-02-27 | C |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| EGP | EastGroup Properties, Inc. | Q4 2023 | 2024-02-08 | B |
| GPRO | GoPro, Inc. | Q4 2023 | 2024-02-07 | F |
| GPRE | Green Plains Inc. | Q4 2023 | 2024-02-07 | F |
| RDCM | RADCOM Ltd. | Q4 2023 | 2024-01-31 | A |
| HP | Helmerich & Payne, Inc. | Q1 2024 | 2024-01-30 | C |
| CHT | Chunghwa Telecom Co., Ltd. | Q4 2023 | 2024-01-30 | C |
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| CPRT | Copart, Inc. | Q1 2024 | 2023-11-16 | B+ |
| ICCM | IceCure Medical Ltd | Q3 2023 | 2023-11-15 | D |
| EFXT | Enerflex Ltd. | Q3 2023 | 2023-11-09 | C+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| MEG | Montrose Environmental Group, Inc. | Q3 2023 | 2023-11-08 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| CMPS | COMPASS Pathways plc | Q3 2023 | 2023-11-04 | F |
| GOLD | Barrick Gold Corporation | Q3 2023 | 2023-11-02 | C |
| AEP | American Electric Power Company, Inc. | Q3 2023 | 2023-11-02 | C+ |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| APAM | Artisan Partners Asset Management Inc. | Q3 2023 | 2023-11-01 | C+ |
| GRBK | Green Brick Partners, Inc. | Q3 2023 | 2023-11-01 | B |
| FSBC | Five Star Bancorp | Q3 2023 | 2023-10-31 | B |
| CMG | Chipotle Mexican Grill, Inc. | Q3 2023 | 2023-10-27 | B+ |
| ANGO | AngioDynamics, Inc. | Q1 2024 | 2023-10-04 | B |
| PTN | Palatin Technologies, Inc. | Q4 2023 | 2023-09-29 | D |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| BZUN | Baozun Inc. | Q2 2023 | 2023-08-28 | D |
| DXLG | Destination XL Group, Inc. | Q2 2023 | 2023-08-24 | D |
| KMDA | Kamada Ltd. | Q2 2023 | 2023-08-16 | B+ |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| TGLS | Tecnoglass Inc. | Q2 2023 | 2023-08-08 | A |
| HE | Hawaiian Electric Industries, Inc. | Q2 2023 | 2023-08-07 | C |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| PTLO | Portillo's Inc. | Q2 2023 | 2023-08-05 | B |
| ET | Energy Transfer LP | Q2 2023 | 2023-08-02 | C+ |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| CTO | CTO Realty Growth, Inc. | Q2 2023 | 2023-07-28 | B |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| IMAX | IMAX Corporation | Q2 2023 | 2023-07-26 | B+ |
| DAL | Delta Air Lines, Inc. | Q2 2023 | 2023-07-13 | A |
| GVP | GSE Systems, Inc. | Q1 2023 | 2023-05-15 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| GGR | Gogoro Inc. | Q1 2023 | 2023-05-11 | D |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SU | Suncor Energy Inc. | Q1 2023 | 2023-05-09 | C+ |
| SLDP | Solid Power, Inc. | Q1 2023 | 2023-05-08 | C+ |
| THS | TreeHouse Foods, Inc. | Q1 2023 | 2023-05-08 | B+ |
| ULCC | Frontier Group Holdings, Inc. | Q1 2023 | 2023-05-07 | C+ |
| INGN | Inogen, Inc. | Q1 2023 | 2023-05-05 | F |
| SBRA | Sabra Health Care REIT, Inc. | Q1 2023 | 2023-05-04 | B |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| TSSI | TSS, Inc. | Q4 2022 | 2023-04-03 | D |
| BEAT | BioTelemetry's | Q4 2022 | 2023-03-17 | D |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| DKS | DICK'S Sporting Goods, Inc. | Q4 2022 | 2023-03-07 | B |
| M | Macy's, Inc. | Q4 2022 | 2023-03-02 | D |
| TGT | Target Corporation | Q4 2022 | 2023-02-28 | C |
| CRBG | Corebridge Financial, Inc. | Q4 2022 | 2023-02-22 | B |
| OEC | Orion Engineered Carbons S.A. | Q4 2022 | 2023-02-17 | B+ |
| TOST | Toast, Inc. | Q4 2022 | 2023-02-16 | C+ |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| HIW | Highwoods Properties, Inc. | Q4 2022 | 2023-02-08 | B |
| CEIX | CONSOL Energy Inc. | Q4 2022 | 2023-02-07 | B |
| UAL | United Airlines Holdings, Inc. | Q4 2022 | 2023-01-18 | B |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| ARWR | Arrowhead Pharmaceuticals, Inc. | Q4 2022 | 2022-11-28 | D |
| CIG | Companhia Energética de Minas Gerais | Q3 2022 | 2022-11-16 | C+ |
| CUE | Cue Biopharma, Inc. | Q3 2022 | 2022-11-14 | D |
| PKOH | Park-Ohio Holdings Corp. | Q3 2022 | 2022-11-13 | B |
| BLZE | Backblaze, Inc. | Q3 2022 | 2022-11-11 | D |
| CLSD | Clearside Biomedical, Inc. | Q3 2022 | 2022-11-09 | C |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| MEC | Mayville Engineering Company, Inc. | Q3 2022 | 2022-11-05 | B+ |
| CHE | Chemed Corporation | Q3 2022 | 2022-11-01 | B+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| PKX | POSCO Holdings Inc. | Q3 2022 | 2022-10-24 | D |
| ASTS | AST SpaceMobile, Inc. | Q2 2022 | 2022-08-15 | D |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| IT | Gartner, Inc. | Q2 2022 | 2022-08-02 | A |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| LTBR | Lightbridge Corporation | Q2 2022 | 2022-07-28 | D |
| LIN | Linde plc | Q2 2022 | 2022-07-28 | B+ |
| JBHT | J.B. Hunt Transport Services, Inc. | Q2 2022 | 2022-07-19 | C+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| KFY | Korn Ferry | Q4 2022 | 2022-06-22 | B |
| SQM | Sociedad Química y Minera de Chile S.A. | Q1 2022 | 2022-05-19 | C+ |
| YALA | Yalla Group Limited | Q1 2022 | 2022-05-17 | C |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| ZVIA | Zevia PBC | Q1 2022 | 2022-05-12 | B |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| WHF | WhiteHorse Finance, Inc. | Q1 2022 | 2022-05-10 | B+ |
| IRTC | iRhythm Technologies, Inc. | Q1 2022 | 2022-05-07 | C+ |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| CCRN | Cross Country Healthcare, Inc. | Q1 2022 | 2022-05-04 | B |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| STC | Stewart Information Services Corporation | Q1 2022 | 2022-04-29 | C+ |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| ZENV | Zenvia Inc. | Q4 2021 | 2022-03-17 | C+ |
| SOPH | SOPHiA GENETICS SA | Q4 2021 | 2022-03-15 | C |
| HROW | Harrow Health, Inc. | Q4 2021 | 2022-03-10 | C |
| RELY | Remitly Global, Inc. | Q4 2021 | 2022-03-02 | B |
| KD | Kyndryl Holdings, Inc. | Q4 2021 | 2022-03-01 | C+ |
| AKAM | Akamai Technologies, Inc. | Q4 2021 | 2022-02-15 | B |
| FORM | FormFactor, Inc. | Q4 2021 | 2022-02-02 | B |
| FFIC | Flushing Financial Corporation | Q4 2021 | 2022-01-28 | B |
| HFWA | Heritage Financial Corporation | Q4 2021 | 2022-01-27 | A |
| EXP | Eagle Materials Inc. | Q3 2022 | 2022-01-27 | B |
| LC | LendingClub Corporation | Q4 2021 | 2022-01-26 | A |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| ZH | Zhihu Inc. | Q3 2021 | 2021-11-22 | D |
| RNW | ReNew Energy Global Plc | Q2 2022 | 2021-11-18 | C |
| LOW | Lowe's Companies, Inc. | Q3 2021 | 2021-11-17 | B+ |
| BFI | BurgerFi International, Inc. | Q3 2021 | 2021-11-12 | C |
| CXW | CoreCivic, Inc. | Q3 2021 | 2021-11-09 | C |
| HNRG | Hallador Energy Company | Q3 2021 | 2021-11-09 | C+ |
| AKBA | Akebia Therapeutics, Inc. | Q3 2021 | 2021-11-09 | C+ |
| ALHC | Alignment Healthcare, Inc. | Q3 2021 | 2021-11-06 | B+ |
| KTB | Kontoor Brands, Inc. | Q3 2021 | 2021-11-04 | A |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| WMB | The Williams Companies, Inc. | Q3 2021 | 2021-11-02 | B |
| LMAT | LeMaitre Vascular, Inc. | Q3 2021 | 2021-10-29 | C+ |
| MD | Pediatrix Medical Group, Inc. | Q3 2021 | 2021-10-28 | B |
| FFWM | First Foundation Inc. | Q3 2021 | 2021-10-26 | B |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| TJX | The TJX Companies, Inc. | Q2 2021 | 2021-08-18 | C |
| EGY | VAALCO Energy, Inc. | Q2 2021 | 2021-08-12 | B |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| KNDI | Kandi Technologies Group, Inc. | Q2 2021 | 2021-08-09 | F |
| LOPE | Grand Canyon Education, Inc. | Q2 2021 | 2021-08-08 | C |
| GNK | Genco Shipping & Trading Limited | Q2 2021 | 2021-08-07 | A |
| UFI | Unifi, Inc. | Q4 2021 | 2021-08-07 | B |
| CLVT | Clarivate Plc | Q2 2021 | 2021-07-31 | B+ |
| AX | Axos Financial, Inc. | Q4 2021 | 2021-07-29 | C+ |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| TENB | Tenable Holdings, Inc. | Q2 2021 | 2021-07-27 | A |
| TCBI | Texas Capital Bancshares, Inc. | Q2 2021 | 2021-07-21 | F |
| ADSK | Autodesk, Inc. | Q3 2019 | 2018-11-20 | A |
| PRPO | Precipio, Inc. | Q3 2018 | 2018-11-19 | D |
| GECC | Great Elm Capital Corporation | Q3 2018 | 2018-11-13 | B |
| OGE | OGE Energy Corp. | Q3 2018 | 2018-11-08 | A |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| UMH | UMH Properties, Inc. | Q3 2018 | 2018-11-02 | C+ |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| WES | Western Midstream Partners, LP | Q3 2018 | 2018-10-31 | D |
| CUBI | Customers Bancorp, Inc. | Q3 2018 | 2018-10-26 | C+ |
| T | AT&T Inc. | Q3 2018 | 2018-10-24 | C+ |
| STM | STMicroelectronics NV | Q3 2018 | 2018-10-24 | C+ |
| LRN | Stride, Inc. | Q1 2019 | 2018-10-23 | B |
| ALKS | Alkermes plc | Q3 2018 | 2018-10-23 | C |
| AU | AngloGold Ashanti's | Q2 2018 | 2018-08-20 | B |
| KOP | Koppers Holdings Inc. | Q2 2018 | 2018-08-12 | C+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| SO | The Southern Company | Q2 2018 | 2018-08-08 | D |
| SRDX | Surmodics, Inc. | Q3 2018 | 2018-08-06 | A |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| TMHC | Taylor Morrison Home Corporation | Q2 2018 | 2018-08-01 | B |
| FMS | Fresenius Medical Care AG & Co. KGaA | Q2 2018 | 2018-07-31 | C |
| XOM | Exxon Mobil Corporation | Q2 2018 | 2018-07-27 | C |
| KIM | Kimco Realty Corporation | Q2 2018 | 2018-07-26 | B+ |
| CP | Canadian Pacific Railway Limited | Q2 2018 | 2018-07-19 | B+ |
| ASND | Ascendis Pharma A/S | Q1 2018 | 2018-05-30 | C+ |
| CLMT | Calumet Specialty Products Partners, L.P | Q1 2018 | 2018-05-16 | C+ |
| LAUR | Laureate Education, Inc. | Q1 2018 | 2018-05-13 | B+ |
| NOVT | Novanta Inc. | Q4 2017 | 2018-05-12 | B+ |
| FSS | Federal Signal Corporation | Q1 2018 | 2018-05-12 | A |
PPC · Q1 2024 → YESThe question is: On this call, when management explains what stands between the company's current results and a meaningfully larger amount of business, are the obstacles it actually narrates ITS OWN E...YES The transcript frames the path to more business as already underway through operational improvements (hatchability and livability gains), facility expansions in Mexico, and the startup of a protein conversion facility. Management describes these as practical steps—building, ramping, and qualifying capacity—that are in progress, directly addressing current limitations in 2023 results. Demand is tied to customer growth and industry tailwinds like protein switching, but the obstacles cited are internal execution and timing, not competitive battles. No emphasis is placed on winning deals against rivals or pricing strategies; instead, the focus remains on the company's own throughput and readiness.
EVBN · Q4 2016 → YESThe question is: On this call, when management explains what stands between the company's current results and a meaningfully larger amount of business, are the obstacles it actually narrates ITS OWN E...YES The transcript shows management narrating a real path to more business already in motion—market disruption from the KeyBank/First Niagara combination, organic capture, new branch openings, insurance agency acquisitions, core system conversions, hiring, and municipal banking department startup—with concrete operator-level work underway. The obstacles to scaling are framed as internal execution and calendar realities (18-24 month loan migration timelines, 9-month deposit ramps), not as demand being contested against rivals. While some competitive positioning language appears, it does not override the core account of growth limits as throughput and timing constraints rather than win-rate battles.
UPLD · Q4 2017 → YESThe question is: On this call, when management explains what stands between the company's current results and a meaningfully larger amount of business, are the obstacles it actually narrates ITS OWN E...NO The transcript centers on M&A-driven growth through acquisitions and integrations, with organic growth described as flat to 5% and not essential. Management frames the path to more business around building integration capabilities, hiring, training, qualifying, and ramping operations post-acquisition, which aligns with execution and calendar constraints. However the discussion includes competitive elements such as replacing incumbents and displacing rivals in some cases, which introduces a contest for demand. Additionally, the narrative emphasizes the company's own readiness and pipeline rather than purely external factors, but the competitive mentions prevent a clean YES under the criteria.